Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Paul J. Tacken, Carl G. Figdor
Seminars in Immunology (2011) Vol. 23, Iss. 1, pp. 12-20
Closed Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Cancer immunotherapy via dendritic cells
Karolina Palucka, Jacques Banchereau
Nature reviews. Cancer (2012) Vol. 12, Iss. 4, pp. 265-277
Open Access | Times Cited: 1842
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka, Jacques Banchereau
Immunity (2013) Vol. 39, Iss. 1, pp. 38-48
Open Access | Times Cited: 790
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
Gerty Schreibelt, Lieke J.J. Klinkenberg, Luis J. Cruz, et al.
Blood (2012) Vol. 119, Iss. 10, pp. 2284-2292
Open Access | Times Cited: 227
Targeting C-type lectin receptors with multivalent carbohydrate ligands
Bernd Lepenies, Junghoon Lee, Sanjiv Sonkaria
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 9, pp. 1271-1281
Closed Access | Times Cited: 226
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz, Rodney Alexander Rosalia, Jan Willem Kleinovink, et al.
Journal of Controlled Release (2014) Vol. 192, pp. 209-218
Closed Access | Times Cited: 207
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 172
Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 131
Dendritic Cell-Targeted Vaccines
Lillian B. Cohn, Lélia Delamarre
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 179
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken, Ingrid S. Zeelenberg, Luis J. Cruz, et al.
Blood (2011) Vol. 118, Iss. 26, pp. 6836-6844
Open Access | Times Cited: 165
Mucosal vaccines: Strategies and challenges
Miao Li, Yi Wang, Yuan Sun, et al.
Immunology Letters (2019) Vol. 217, pp. 116-125
Closed Access | Times Cited: 141
Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
Stuart M. Levitz, Douglas T. Golenbock
Cell (2012) Vol. 148, Iss. 6, pp. 1284-1292
Open Access | Times Cited: 135
Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives
João Constantino, Célia Gomes, Amílcar Falcão, et al.
Translational research (2015) Vol. 168, pp. 74-95
Closed Access | Times Cited: 134
Dendritic cell-based nanovaccines for cancer immunotherapy
Leonie E. Paulis, Subhra Mandal, Martin Kreutz, et al.
Current Opinion in Immunology (2013) Vol. 25, Iss. 3, pp. 389-395
Closed Access | Times Cited: 134
Cancer Immunotherapy via Dendritic Cells
Karolina Palucka, Jacques Banchereau
(2013), pp. 75-89
Closed Access | Times Cited: 127
Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
Ronnie H. Fang, Ashley V. Kroll, Liangfang Zhang
Small (2015) Vol. 11, Iss. 41, pp. 5483-5496
Open Access | Times Cited: 117
Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells
Sreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
The Journal of Immunology (2014) Vol. 193, Iss. 4, pp. 1622-1635
Open Access | Times Cited: 116
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 2, pp. 146-156
Open Access | Times Cited: 111
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
Anne Huber, Floris Dammeijer, Joachim G.J.V. Aerts, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 110
19F magnetic resonance imaging of endogenous macrophages in inflammation
Sebastian Temme, Florian Bönner, Jürgen Schrader, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2012) Vol. 4, Iss. 3, pp. 329-343
Closed Access | Times Cited: 108
Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration
Sanyog Jain, Harshad Harde, Anura Indulkar, et al.
Nanomedicine Nanotechnology Biology and Medicine (2013) Vol. 10, Iss. 2, pp. 431-440
Closed Access | Times Cited: 106
Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
Md Kamal Hossain, Katherine A. Wall
Cancers (2019) Vol. 11, Iss. 3, pp. 418-418
Open Access | Times Cited: 77
Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect
Furong Cheng, Ting Su, Shurong Zhou, et al.
Science Advances (2023) Vol. 9, Iss. 28
Open Access | Times Cited: 39
Boosting antibody responses by targeting antigens to dendritic cells
Irina Caminschi, Ken Shortman
Trends in Immunology (2011) Vol. 33, Iss. 2, pp. 71-77
Closed Access | Times Cited: 87
Antigen Cross-Presentation of Immune Complexes
Barbara Platzer, Madeleine Stout, Edda Fiebiger
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 85
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
Christian H.K. Lehmann, Lukas Heger, Gordon F. Heidkamp, et al.
Vaccines (2016) Vol. 4, Iss. 2, pp. 8-8
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top